ArticlePharmaceuticals (Basel, Switzerland)2018

Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.

Mónica Fernández-Cancio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.